Caladrius Biosciences, Inc. (CLBS) financial statements (2022 and earlier)

Company profile

Business Address 110 ALLEN ROAD
BASKING RIDGE, NJ 07920
State of Incorp. DE
Fiscal Year End December 31
SIC 809 - Miscellaneous Health And Allied Services, Not (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:24,64716,51222,76837,81851,8854,4276,876
Cash and cash equivalents24,64716,51214,03210,299 14,70520,318
Short-term investments    25,917  
Other undisclosed cash, cash equivalents, and short-term investments  8,73627,51925,968(10,278)(13,443)
Receivables    2342,8922,566
Other undisclosed current assets71,53518,8193,2046,2888,99117,33019,831
Total current assets:96,18235,33125,97244,10661,11024,64929,272
Noncurrent Assets
Property, plant and equipment625710016525717,14917,065
Intangible assets, net (including goodwill)     9,3219,891
Goodwill     7,0137,013
Intangible assets, net (excluding goodwill)     2,3082,878
Other noncurrent assets7646141,0813091,434713977
Other undisclosed noncurrent assets    575  
Total noncurrent assets:8266711,1814742,26627,18427,933
TOTAL ASSETS:97,00836,00227,15344,58063,37651,83357,205
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,5233,5065,9765,6199,154  
Accounts payable1,9341,0201,4907621,343  
Accrued liabilities2,5892,4864,4864,8577,811  
Debt    159  
Other undisclosed current liabilities     19,50121,015
Total current liabilities:4,5233,5065,9765,6199,31319,50121,015
Noncurrent Liabilities
Long-term debt and lease obligation     2,52510,829
Long-term debt, excluding current maturities     2,52510,829
Liabilities, other than long-term debt4852546241,5073,8736,0481,495
Deferred revenue and credits 4,587 
Deferred tax liabilities, net  1,071933
Other liabilities4852546241,5073,873390562
Other undisclosed noncurrent liabilities     19,79421,598
Total noncurrent liabilities:4852546241,5073,87328,36633,921
Other undisclosed liabilities     (101)(21,015)
Total liabilities:5,0083,7606,6007,12613,18647,76633,921
Stockholders' equity
Stockholders' equity attributable to parent92,25432,49620,81637,72650,5084,88423,714
Preferred stock    000
Common stock601911109857
Treasury stock, value(708)(708)(708)(708)(708)(708)(708)
Additional paid in capital545,988458,748438,911436,433433,044410,372396,496
Accumulated other comprehensive income (loss)(70)(13)2(32)(28) 0
Accumulated deficit(453,016)(425,550)(417,400)(397,977)(381,810)(404,789)(372,132)
Stockholders' equity attributable to noncontrolling interest(254)(254)(263)(272)(318)(817)(430)
Total stockholders' equity:92,00032,24220,55337,45450,1904,06623,284
TOTAL LIABILITIES AND EQUITY:97,00836,00227,15344,58063,37651,83357,205

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues    1,90035,28422,488
Revenue, net1,900  
Cost of revenue     (31,136)(20,159)
Gross profit:    1,9004,1482,329
Operating expenses(29,050)(19,145)(20,092)(16,987)(27,593)(66,620)(136,337)
Other undisclosed operating income (loss)    (1,900)31,13620,159
Operating loss:(29,050)(19,145)(20,092)(16,987)(27,593)(31,336)(113,849)
Nonoperating income (expense)76132740819(105)(1,836)15,595
Investment income, nonoperating151      
Other nonoperating income (expense)(75)1327408242732217,724
Interest and debt expense   (5)(378)(1,858)(2,128)
Loss from continuing operations before equity method investments, income taxes:(28,974)(19,013)(19,352)(16,173)(28,075)(35,029)(100,382)
Other undisclosed income from continuing operations before income taxes   53781,8582,128
Loss from continuing operations before income taxes:(28,974)(19,013)(19,352)(16,168)(27,698)(33,171)(98,254)
Income tax expense (benefit)1,50810,872  11,527(138)17,244
Loss from continuing operations:(27,466)(8,141)(19,352)(16,168)(16,171)(33,310)(81,011)
Income from discontinued operations    38,399  
Net income (loss):(27,466)(8,141)(19,352)(16,168)22,228(33,310)(81,011)
Other undisclosed net income (loss) attributable to parent (9)(9)1751  
Net income (loss) attributable to parent:(27,466)(8,150)(19,361)(16,167)22,979(33,310)(81,011)
Other undisclosed net income available to common stockholders, basic     653125
Net income (loss) available to common stockholders, diluted:(27,466)(8,150)(19,361)(16,167)22,979(32,656)(80,886)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(27,466)(8,141)(19,352)(16,168)22,228(33,310)(81,011)
Other comprehensive income (loss)(57)(15)34(4)(28)(0)(1)
Comprehensive income (loss):(27,523)(8,156)(19,318)(16,172)22,200(33,310)(81,011)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest (9)(9)1751653125
Comprehensive income (loss), net of tax, attributable to parent:(27,523)(8,165)(19,327)(16,171)22,951(32,657)(80,887)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: